Mainz, Germany On a Friday in late January, Ugur Sahin received an email with bad news: A new study of a deadly new coronavirus in China suggests it is more contagious than previously thought. He believed the outbreak was likely to be an epidemic. The following Monday, the chief executive …
Read More »Volunteers infected with coronavirus in vaccine-effectiveness tests in the UK
LONDON – Researchers in the UK are planning the first of its kind to quickly gauge the effectiveness of multiple vaccines against Covid-19 by launching an infection of healthy volunteers with a tightly controlled dose of coronavirus in early 2021. The so-called humanitarian challenge plans target children aged 18 to …
Read More »Pfizer will be able to apply for emergency use of the Covid-19 vaccine in late November
Pfizer Inc. P.F.E. -0.84% Said it may be ready to apply for emergency-use authorization of its Covid-19 vaccine by the end of November, believing that in late-stage human trials will yield positive efficacy and safety data, the first time it or any other leading Western vaccine developer This kind of …
Read More »European stocks, U.S. Futures lose momentum
File – This September 2020 photo, provided by Johnson & Johnson, shows a single-dose COVID-19 vaccine being developed by the company. A.P. European stocks held lower on Tuesday, with traders losing momentum after halting key coronavirus trials waiting for earnings from some of the world’s leading banks. Stocks Europe 600 …
Read More »Indonesia has 270 million people and one of the lowest Covid-19 test rates in the world
Seven months after its first coronavirus case was reported, the world’s fourth most populous country still has a large number of blind flights. An archipelago of 270 million people, Indonesia has tested a smaller portion of its population than any other major economy. According to Our World in Data, a …
Read More »